| Daniel Polchinski, PHARMD | |
|
500 Pasteur Dr, Palo Alto, CA 94304-1048 | |
| (650) 497-1672 | |
| Not Available |
| Full Name | Daniel Polchinski |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 500 Pasteur Dr, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568187326 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 74884 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Polchinski, PHARMD 500 Pasteur Dr, Palo Alto, CA 94304-1048 Ph: () - | Daniel Polchinski, PHARMD 500 Pasteur Dr, Palo Alto, CA 94304-1048 Ph: (650) 497-1672 |
News Archive
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three and six months ended June 30, 2010.
Merck, known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application for suvorexant, Merck's investigational medicine for the treatment of insomnia.
Mothers' vitamin D levels at a gestation of 26 weeks or less were positively related to birth weight and head circumference, and, in the first trimester were negatively associated with risk of a baby being born small for gestational age, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing Authorization Application, or MAA, from the European Medicines Agency for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of type 2 diabetes.
› Verified 9 days ago
Dr. Laura Elizabeth Stoddard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
See Lor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Jaimini Shah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Avenue, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Tam Bang Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4170 El Camino Real, Palo Alto, CA 94306 Phone: 650-858-2007 | |
Nidhu Baby Abraham, PHARM.D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Eric Fujii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd Ste 108, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Thuy Diem Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda, Palo Alto, CA 94034 Phone: 650-493-5000 |